Clinical trial
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating…
NCT00227747 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00227747 |
|---|---|
| Title | Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer |
| Official title | Randomized Phase III Trial Comparing in a Preoperative Schedule the Result of Two Concurrent Chemoradiation Schemes (45 Gy + Capecitabine vs 50 Gy + Capecitabine - Oxaliplatin) on the Rate of Sterilization of the Operative Specimen in Resectable Rectal Carcinomas T3-4 No-2 Mo |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | capecitabine, oxaliplatin, conventional surgery, neoadjuvant therapy, radiation therapy |
| Enrollment | 598 |
| Start date | Nov 8, 2005 |
| Primary completion | Oct 22, 2008 |
| Completion | Jul 15, 2013 |
| First posted | Sep 28, 2005 |
| Last update posted | Feb 17, 2021 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: